UBS AM’s China Biologic Products Holdings, Inc. CBPO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-4,788
| Closed | -$567K | – | 2822 |
|
|
2021
Q1 | $567K | Sell |
4,788
-1,490
| -24% | -$176K | ﹤0.01% | 2342 |
|
|
2020
Q4 | $741K | Hold |
6,278
| – | – | ﹤0.01% | 2129 |
|
|
2020
Q3 | $698K | Buy |
6,278
+2,708
| +76% | +$301K | ﹤0.01% | 1983 |
|
|
2020
Q2 | $365K | Hold |
3,570
| – | – | ﹤0.01% | 2233 |
|
|
2020
Q1 | $385K | Hold |
3,570
| – | – | ﹤0.01% | 2074 |
|
|
2019
Q4 | $415K | Sell |
3,570
-5,271
| -60% | -$613K | ﹤0.01% | 2297 |
|
|
2019
Q3 | $1.01M | Buy |
8,841
+4,902
| +124% | +$561K | ﹤0.01% | 1945 |
|
|
2019
Q2 | $375K | Sell |
3,939
-29,331
| -88% | -$2.8M | ﹤0.01% | 2330 |
|
|
2019
Q1 | $3.04M | Sell |
33,270
-177,454
| -84% | -$16.2M | ﹤0.01% | 1339 |
|
|
2018
Q4 | $16M | Buy |
210,724
+5,300
| +3% | +$402K | 0.01% | 754 |
|
|
2018
Q3 | $16.4M | Buy |
+205,424
| New | +$16.4M | 0.01% | 812 |
|
|
2017
Q3 | – | Sell |
-225,140
| Closed | -$25.5M | – | 2587 |
|
|
2017
Q2 | $25.5M | Buy |
225,140
+26,920
| +14% | +$3.04M | 0.02% | 656 |
|
|
2017
Q1 | $19.8M | Buy |
198,220
+16,933
| +9% | +$1.7M | 0.02% | 719 |
|
|
2016
Q4 | $19.5M | Buy |
181,287
+3,217
| +2% | +$346K | 0.02% | 692 |
|
|
2016
Q3 | $22.2M | Sell |
178,070
-23,195
| -12% | -$2.89M | 0.02% | 644 |
|
|
2016
Q2 | $21.4M | Buy |
201,265
+6,509
| +3% | +$692K | 0.02% | 649 |
|
|
2016
Q1 | $22.3M | Buy |
194,756
+3,977
| +2% | +$455K | 0.03% | 622 |
|
|
2015
Q4 | $27.2M | Sell |
190,779
-231
| -0.1% | -$32.9K | 0.03% | 546 |
|
|
2015
Q3 | $17.2M | Buy |
191,010
+29,381
| +18% | +$2.64M | 0.02% | 724 |
|
|
2015
Q2 | $18.6M | Buy |
+161,629
| New | +$18.6M | 0.02% | 739 |
|